I completely agree with Melanie. The agents received are generally eliminated within 48 hours after being taken/infused. You may want to also remind the team that exposure occurs to bodily fluids, such as urine
or stool. Unlike with patients they care for, it is not likely that any of them will be cleaning up their coworker or emptying her bedpan/Foley device.
The talk on the unit does need to be shut down. They should treat their coworker with the dignity and respect that she deserves and focus on doing their work, not talking about her, her medical condition or
the medication she takes.
Laura
Laura L Radke, MD
Adjunct Assistant Professor of Medicine
Senior Medical Director, F&MCW Occupational Health Services
Phone: 262-253-8197 | Fax: 262-253-5152 Cell Phone: 414-530-0723
E-mail:
laura.radke@froedtert.com
Froedtert & the Medical College of Wisconsin Workforce Health / North Hills Health Center
Building B First Floor
W129 N7055 Northfield Dr.
Menomonee Falls, WI 53051
From: MCOH-EH <mcoh-eh-bounces+laura.radke=froedtert.com@mylist.net>
On Behalf Of Swift, Melanie D., M.D., M.P.H. via MCOH-EH
Sent: Tuesday, March 19, 2024 8:30 AM
To: MCOH-EH <mcoh-eh@mylist.net>
Cc: Swift, Melanie D., M.D., M.P.H. <Swift.Melanie@mayo.edu>
Subject: Re: [MCOH-EH] IV Chemotherapy and return to work
|
Hi Darryl, very interesting question. As a first step I would talk directly with the employee in question to clarify a few things
as Kevin points out below.The type of chemo and anticipated side effects matter as well as the schedule. Her oncologist will have prepared her for wha |
Hi Darryl, very interesting question. As a first step I would talk directly with the employee in question to clarify a few things as Kevin points out below.
The type of chemo and anticipated side effects matter as well as the schedule. Her oncologist will have prepared her for what to expect. Most SE appear in the 1 – 2 days following chemo. Some
workers will schedule their chemo to precede a couple of days away from work (e.g. on a Friday afternoon if they work M-F). I’d want to be sure that she takes the time away from work she will need to feel well enough to be working. Trying to “power through”
is not a good plan for anyone.
For most agents, toxic metabolites would be excreted in urine within 72 hrs. If she’s getting an agent that would still be getting excreted in urine while at work, there are some standard practices
of double flushing and wiping down the seat. She should flush either with the lid down or while remaining seated (there may not be any lids in healthcare facility toilets). As Kevin notes, some chemo is excreted in sweat, but skin-to-skin contact with others
should not be likely in the workplace. Here are some safety resources from the ACS about post-chemo safety including safety to others:
https://www.cancer.org/cancer/managing-cancer/treatment-types/chemotherapy/chemotherapy-safety.html
Finally the rumor mill on her unit should be quelled. I’d recommend speaking with the manager to reassure them you’ve talked with the employee in question and ensured that her RTW plan is safe;
and ask the manager to reassure any concerned coworkers and remind them of the need to respect the worker’s medical privacy.
Thanks,
Melanie
From: MCOH-EH <mcoh-eh-bounces@mylist.net>
On Behalf Of Smith, Kevin
Sent: Monday, March 18, 2024 1:27 PM
To: MCOH-EH <mcoh-eh@mylist.net>
Subject: [EXTERNAL] Re: [MCOH-EH] IV Chemotherapy and return to work
Darryl,
Interesting question. I assume the concern is for "secondhand" exposure to chemo agents?
My first thought would be getting with her provider to see what regimen she is on, assuming they send her to you for an evaluation and you can get a release to discuss her case
with her provider. A brief review of the pharmacology of the agents should inform you regarding toxicity, half-life, routes of elimination (renal/liver) and whether or not excreted in sweat. Should also tell you if excreted unchanged or metabolized to inactive
compounds, etc.
I would think the heme/onc folks may have some professional society guidelines/data on such questions they may be able to share.
This should help with a risk assessment/mitigation (if needed)/communication strategy for the area in question.
Hope this helps!
Good luck!
Kevin M. Smith, MD, MPH, FACOEM
Medical Director
Phoebe Corporate Health
Phoebe Employee Health Services
229-312-9220
229-889-7074 Fax
From: MCOH-EH <mcoh-eh-bounces@mylist.net> on behalf of Lesoski, Darryl via MCOH-EH <mcoh-eh@mylist.net>
Sent: Monday, March 18, 2024 10:29 AM
To: MCOH/EH <mcoh-eh@mylist.net>
Cc: Lesoski, Darryl <DLESOSKI@mhc.net>
Subject: [MCOH-EH] IV Chemotherapy and return to work
SO SORRY for all my questions but they just keep popping up!!
😊 Here is a question from our administration staff: I have a question and not sure if you can help me or not. I have an
employee who is getting IV chemo every 3 weeks, and
ZjQcmQRYFpfptBannerStart
This Message Is From an External Sender
This message came from outside your organization.
ZjQcmQRYFpfptBannerEnd
SO SORRY for all my questions but they just keep popping up!!
😊
Here is a question from our administration staff:
I have a question and not sure if you can help me or not. I have an employee who is getting IV chemo every 3 weeks, and she was told by her physician that she was safe to come back to work after that. I have staff questioning if that is true and asking to
be trained on chem precautions. I reached out to HR and they thought you may be able to help.
Can anyone point me to a reliable source of information? Do you have a policy in place that addresses this concern? What approach do you take at your medical center?
Looking for voices of reason and sound expert advise which is why I turn to all of you!!! THANKS ahead of time.
Darryl
Darryl Lesoski, MD, MPH, FACOEM
System Medical Director – Occupational Health and Medicine, Employee Health
Munson Medical Center
Munson Occupational Health and Medicine
Email:
dlesoski@mhc.net
TRAVERSE CITY
Mailing: 1105 Sixth Street, FFCHC, Occ Medicine 49684
Physical: 550 Munson Avenue, 1st Floor 49686
Office 231-935-8590 | Fax 231-935-8597
CADILLAC
Address: 803 Lynn Street, Cadillac 49601
Office 231-876-6180 | Fax 231-876-6080
GRAYLING
Address: 1100 East Michigan Ave, Grayling 49738
Office 989-348-0368 | Fax 989-348-0773
ELMIRA
Address: 2572 US-131, Elmira 49730
Office 989-731-7700 | Fax 231-231-8714
Confidentiality Statement: This e-mail message, including any attachments, is intended only for the use of the recipient(s) and may contain privileged and confidential information, including
information that is protected under the HIPAA privacy rules. Any unauthorized review, disclosure, copying, distribution, or use is prohibited. If you have received this e-mail by mistake, please notify us immediately by reply e-mail and destroy all copies
of the original message.
Disclaimer: The HIPAA Final Privacy Rule requires covered entities to safeguard certain Protected Health Information (PHI) related to a person’s healthcare. Information being emailed to you may include PHI after appropriate authorization
from the patient or under circumstances that do not require patient authorization. You, the recipient, are obligated to maintain PHI in a safe and secure manner. You may not re-disclose without additional patient consent or as required by law. Unauthorized
re-disclosure or failure to safeguard PHI could subject you to penalties described in federal (HIPAA) and state law. If you, the reader of this message are not the intended recipient, or the employee or agent responsible to deliver it to the intended recipient,
please notify us immediately and destroy.